Please use this identifier to cite or link to this item:
|Title:||Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.||Austin Authors:||Yeow, Marcus;Zhao, Joseph J;Fong, Khi Yung;Wong, Joel;Tan, Alvin Yong Hui;Kam, Juinn Huar;Nikfarjam, Mehrdad ;Goh, Brian K P;Kabir, Tousif||Affiliation:||Department of General Surgery, Sengkang General Hospital, Singapore, Singapore.. Department of Hepatopancreatobiliary Surgery, Austin Hospital, 145 Studley Rd, Heidelberg, Melbourne, VIC, 3084, Australia
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore..
Department of General Surgery, Sengkang General Hospital, Singapore, Singapore..
|Issue Date:||Nov-2022||Date:||2022||Publication information:||World Journal of Surgery 2022; 46(11): 2778-2787||Abstract:||An updated systematic review and meta-analysis was conducted to compare radiofrequency ablation (RFA) versus repeat hepatectomy (RH) for patients with recurrent hepatocellular carcinoma (rHCC) after a previous liver resection. PubMed, EMBASE, and Cochrane databases were searched from inception to October 2021 for randomized controlled trials and propensity-score matched studies. Individual participant survival data of disease-free survival (DFS) and overall survival (OS) were extracted and reconstructed followed by one-stage and two-stage meta-analysis. Secondary outcomes were major complications and length of hospital stay (LOHS). A total of seven studies (1317 patients) were analysed. In both one-stage and two-stage meta-analysis, there was no significant difference in OS between the RFA and RH cohorts (Hazard Ratio (HR) 1.15, 95% CI 0.98-1.36, P = 0.094 and HR 1.12, 95% CI 0.77-1.64, P = 0.474 respectively), while the RFA group had a higher hazard rate of disease recurrence compared to the RH group (HR 1.30, 95% CI 1.13-1.50, P < 0.001 and HR 1.31, 95% CI 1.09-1.57, P = 0.013, respectively). RFA was associated with fewer major complications and shorter LOHS versus RH (Odds Ratio 0.34, 95% CI 0.15-0.76, P = 0.009 and Weighted Mean Difference - 4.78, 95% CI - 6.30 to - 3.26, P < 0.001, respectively). RH may be associated with superior DFS for rHCC, at the expense of higher morbidity rate and longer LOHS. However, OS is comparable between both modalities. As such, these techniques may be utilized as complementary strategies depending on individual patient and disease factors. Large-scale, randomized, prospective studies are required to corroborate these findings.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/31028||DOI:||10.1007/s00268-022-06691-x||ORCID:||http://orcid.org/0000-0002-1023-7402||Journal:||World Journal of Surgery||PubMed URL:||35989371||Type:||Journal Article|
|Appears in Collections:||Journal articles|
Show full item record
checked on Sep 27, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.